Rankings
▼
Calendar
OMER Q3 2025 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$835M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$26M
Net Income
-$31M
EPS (Diluted)
$-0.47
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$186M
Total Liabilities
$406M
Stockholders' Equity
-$220M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$26M
-$35M
+25.5%
Net Income
-$31M
-$32M
+4.1%
← Q2 2025
All Quarters